YHB Investment Advisors Inc. Increases Stake in Colgate-Palmolive Company $CL

Key Points

• YHB Investment Advisors increased its Colgate-Palmolive stake by 388% in the third quarter, ending with 51,377 shares valued at approximately $4.38 million. Institutional investors collectively own 80.41% of the company.
• Colgate-Palmolive reported quarterly earnings of $0.99 per share, exceeding estimates by $0.04, while revenue rose 4.9% year over year to $5.36 billion. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $98.65.
• The company declared a quarterly dividend of $0.53 per share, equivalent to an annualized $2.12 payout and a 2.4% yield. Shares recently traded at $88.15, up 1.1%.

YHB Investment Advisors Inc. grew its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 388.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 51,377 shares of the company's stock after buying an additional 40,850 shares during the quarter. YHB Investment Advisors Inc.'s holdings in Colgate-Palmolive were worth $4,383,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CL. TD Capital Management LLC increased its holdings in Colgate-Palmolive by 61.4% during the 4th quarter. TD Capital Management LLC now owns 326 shares of the company's stock worth $26,000 after purchasing an additional 124 shares in the last quarter. Parvin Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the second quarter valued at about $32,000. Park Place Capital Corp lifted its holdings in shares of Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company's stock valued at $33,000 after purchasing an additional 127 shares in the last quarter. Cherry Tree Wealth Management LLC boosted its position in shares of Colgate-Palmolive by 7,840.0% during the second quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company's stock worth $36,000 after buying an additional 392 shares during the period. Finally, Montgomery Financial Services LLC bought a new position in shares of Colgate-Palmolive during the second quarter worth about $36,000. Institutional investors own 80.41% of the company's stock.

Insider Activity

In related news, Director John Cahill sold 4,170 shares of the firm's stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the sale, the director directly owned 28,373 shares in the company, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Noel Wallace sold 161,021 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the transaction, the chief executive officer owned 362,231 shares of the company's stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 175,191 shares of company stock valued at $16,110,903. 0.43% of the stock is owned by company insiders.

Colgate-Palmolive Stock Up 1.1%

Shares of Colgate-Palmolive stock traded up $0.94 on Thursday, reaching $88.15. 1,484,614 shares of the company were exchanged, compared to its average volume of 5,689,970. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a market capitalization of $70.27 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 4.07 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The company has a 50-day moving average of $89.23 and a 200 day moving average of $88.75.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business had revenue of $5.36 billion during the quarter, compared to analysts' expectations of $5.36 billion. During the same period last year, the business earned $0.92 earnings per share. The firm's revenue was up 4.9% on a year-over-year basis. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive's payout ratio is currently 84.13%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CL. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $104.00 to $103.00 and set an "overweight" rating on the stock in a research note on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Jefferies Financial Group reiterated a "hold" rating on shares of Colgate-Palmolive in a report on Monday, August 3rd. Barclays boosted their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $104.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Twelve research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $98.65.

Colgate-Palmolive Profile

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom's of Maine and Hill's Science Diet.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.